Fintech PR
CGTN: How China-proposed BRI helps incense-makers go global
BEIJING, March 3, 2024 /PRNewswire/ — Pu Lianggong knows the art of incense-making, just like his Arab ancestors.
Now nearly 70 years old, Pu produces incense in Yongchun County in Quanzhou, a coastal city in east China’s Fujian Province.
The incense-making craft has its roots in the ancient Maritime Silk Road, which served as a vital conduit for both trade and cultural exchange between China’s southeastern coastal regions and foreign countries.
Pu belongs to a 10th-generation family of Arab descent who settled in Quanzhou, known as the starting point of the ancient Maritime Silk Road, in 1646. As China’s seaborne trade thrived during Song (960-1279) and Yuan (1271-1368) dynasties, Quanzhou became the largest port in eastern China.
Pu’s Arab ancestors brought aromatic ingredients with them along the ancient Maritime Silk Road, made a living by selling them and gradually integrated into life in Quanzhou, marrying locals and adopting the Chinese surname Pu.
The Pu family made incense with bamboo and aromatic ingredients from their homeland, which is different from the scented chips called “bakhoor” in most Arab countries. It is similar to a Chinese incense stick, with bamboo sticks wrapped in ground aromatic ingredients.
Boosted by the Pu family’s influence, incense has become a thriving industry in Yongchun. At present, there are nearly 300 incense-producing factories there, selling products to both domestic and foreign markets.
Thanks to the increase in international orders, workers and their families are enjoying more comfortable lives, an improvement partly driven by the Belt and Road Initiative (BRI).
Proposed by China in 2013, the initiative aims to build trade and infrastructure networks connecting Asia with Europe and beyond along the ancient Silk Road trade routes for common development and prosperity.
Serving as a platform to foster cross-cultural exchange and mutual understanding as well, the initiative presents an opportunity to promote diversity and inclusivity.
Chinese President Xi Jinping once quoted an ancient Chinese saying, “Delicious soup is made by combining different ingredients,” to explain the importance of diversity.
A shared future for mankind
“Delicious soup is made by combining different ingredients.”
The saying comes from the Chinese classic “History of the Three Kingdoms,” literally reflecting the Chinese culinary tradition of using a variety of ingredients, such as herbs, spices and vegetables, to create a flavorful soup. It highlights the power of collaboration and that the value of diversity in human civilization is the source of human progress.
Xi cited it in a keynote speech at the United Nations Office at Geneva in January 2017, saying diversity is “an engine driving the advance of human civilizations.”
“There are more than 200 countries and regions, over 2,500 ethnic groups and multiple religions in our world. Different histories, national conditions, ethnic groups and customs give birth to different civilizations and make the world a colorful one,” said Xi.
“We should make exchanges among civilizations a source of inspiration for advancing human society and a bond that keeps the world in peace.”
Xi emphasized the necessity of building an open and inclusive world through exchanges and mutual learning, adding that exchange among civilizations is “a source of inspiration for advancing human society” and “a bond to keep the world in peace.”
The old Chinese saying is very much in line with the history of incense-making in Yongchun. Centuries ago, Arabic aromatic ingredients came to China as “messengers,” integrated and developed with Chinese aromatic ingredients, and finally spread around the world.
Nowadays, the Arab states, which were important participants along the ancient Silk Road trade routes, are crucial partners with China in the BRI.
Over the past decade, the BRI has positively impacted local residents in partner countries by providing them with job opportunities, as well as facilitating international trade.
From 2013 to 2022, the total trade between China and BRI partner countries reached $19.1 trillion, with an average annual growth rate of 6.4 percent, according to a white paper. By June 2023, China had signed more than 200 BRI cooperation agreements with more than 150 countries and 30 international organizations across five continents, yielding a number of signature projects and small-scale yet impactful projects.
China has also worked to bring BRI partner countries and organizations together through joint cultural activities, including the establishment of international alliances of theaters, museums, art festivals and libraries such as the International Alliance of Museums of the Silk Road and the Silk Road International League of Theaters.
By connecting diverse cultures and different countries, the BRI promotes cooperation, openness and inclusivity around the world, bringing China closer to its goal of building a community with a shared future for mankind to promote common development.
View original content:https://www.prnewswire.co.uk/news-releases/cgtn-how-china-proposed-bri-helps-incense-makers-go-global-302077873.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
B Lab UK research reveals UK public back change to company law to put people, the planet and profit on more equal footing
-
Latest News7 days ago
One United Properties posts a consolidated turnover of 84.3 million euros and a gross profit of 37 million euros in the first three months of 2024
-
Latest News5 days ago
Unleash a Wave of Opportunities this May with Bybit
-
Latest News4 days ago
Bankart migrates payment processing to Diebold Nixdorf’s Vynamic Transaction Middleware
-
Latest News4 days ago
Call for Projects: Over $3 Million Investment for International Audiovisual Contents at TCCF PITCHING 2024
-
Latest News4 days ago
barq and TerraPay Forge a Strategic Partnership
-
Latest News4 days ago
What Does Nuvei’s Go-Private Deal Portend for FinTechs?
-
Latest News4 days ago
ALLCLEAR TRAVEL RESEARCH: ONE IN FOUR PEOPLE WITH MEDICAL CONDITIONS RISK INVALIDATING THEIR TRAVEL INSURANCE WHEN TRAVELLING ABROAD